Skip to main content

MacDonald Brian Richard's Form 4 filing

Disc Medicine, Inc. (IRON) · filed Jun 30, 2023

Accession no.
0000950170-23-031207
Filed
Jun 30, 2023
Trade date
Jun 28-30, 2023
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 10 non-derivative transactions. Open-market sales total $711.1K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
MacDonald Brian RichardCIK 0001952556Officer (Chief Innovation Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 28, 2023Common StockSSaleDisposed−2,247$49.24F2−$110,642.2825,153Direct
Jun 28, 2023Common StockSSaleDisposed−1,900$50.38F3−$95,72223,253Direct
Jun 28, 2023Common StockSSaleDisposed−953$50.80F4−$48,412.422,300Direct
Jun 29, 2023Common StockSSaleDisposed−736$44.37F5−$32,656.3221,564Direct
Jun 29, 2023Common StockSSaleDisposed−2,230$45.49F6−$101,442.719,334Direct
Jun 29, 2023Common StockSSaleDisposed−1,934$46.51F7−$89,950.3417,400Direct
Jun 29, 2023Common StockSSaleDisposed−200$47.24F8−$9,44817,200Direct
Jun 30, 2023Common StockSSaleDisposed−2,923$44.85F9−$131,096.5514,277Direct
Jun 30, 2023Common StockSSaleDisposed−1,401$45.45F10−$63,675.4512,876Direct
Jun 30, 2023Common StockSSaleAcquired+600$46.76F11+$28,05612,276Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.61 to $49.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (11) to this Form 4.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.61 to $50.59, inclusive.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.62 to $51.235, inclusive.

Referenced by the price of 1 transaction in Table I.

F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.03 to $44.87, inclusive.

Referenced by the price of 1 transaction in Table I.

F6

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.03 to $45.94, inclusive.

Referenced by the price of 1 transaction in Table I.

F7

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.04 to $46.96, inclusive.

Referenced by the price of 1 transaction in Table I.

F8

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.23 to $47.25, inclusive.

Referenced by the price of 1 transaction in Table I.

F9

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.31 to $45.29, inclusive.

Referenced by the price of 1 transaction in Table I.

F10

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.31 to $45.58, inclusiv

Referenced by the price of 1 transaction in Table I.

F11

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.56 to $47.00, inclusive.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)